Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in CRC patients after chemotherapy
NCT02169388Phase 1Unknown
- Sponsor
- Shandong University
- Start
- Jun 2014
- Primary completion
- Oct 2014
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in adverse event comparing Probiotic with Placebo (2 arms). Primary endpoints: Composition of Microorganisms in stool after probiotic intervention at 5 months, Short-chain fatty acids in feces of patients after chemotherapy at 5 months and 1 more. Status: unknown.
02
Drugs
clostridium butyricum
03
Conditions
adverse event
Beyond the preview
Go deeper on NCT02169388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169388.